manufacturing

News

Janssen invests $350m in new European biologics production

Janssen is to expand its biologics manufacturing capacity in Europe with a new $350 million (€300 million) investment in its existing site in Ireland.

Events

Partner Content

ManuPharma 2017

ManuPharma 2017 06- 07 December, 2017 | Steigenberger Frankfurter Hof, Frankfurt

News

FDA and EMA reach milestone in sharing confidential informat...

New agreement is culmination of three years of work by FDA and EMA

News

Pfizer to close UK manufacturing sites

Company says decision not linked to Brexit

News

GSK shows confidence in Brexit Britain with manufacturing in...

GSK confident in UK despite Brexit.

News

Novo to expand world's biggest insulin production site

World's largest insulin plant is to get bigger.

Janssen invests $350m in new European biologics production

ManuPharma 2017

FDA and EMA reach milestone in sharing confidential informat...

Pfizer to close UK manufacturing sites

GSK shows confidence in Brexit Britain with manufacturing in...

Novo to expand world's biggest insulin production site

As patents expire, fampridine is cleared for NHS use in MS

Discover a new era of healthcare panel engagement: Grounded ...

manufacturing

Editor's Picks